Archive - September 2023
FDA Accepts Application for Genentech’s Crovalimab for the Treatment of PNH, a Rare Life-Threatening Blood Condition
Exercise Intervention Has Biological Effect in Lynch Syndrome
X4 Pharmaceuticals Announces Submission of New Drug Application (NDA) to U.S. FDA for Mavorixafor in WHIM Syndrome
Benefit of ICD Attenuated in CKD Patients Receiving Cardiac Resynchronization
Aquestive Therapeutics Receives FDA Acceptance Of New Drug Application (NDA) For Libervant (Diazepam) Buccal Film In Pediatric Patients And Assignment Of Prescription Drug User Fee Act (PDUFA) Date
Novel Model Aids Prediction of Survival in Heart Failure With Reduced Ejection Fraction
Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPD
Many Receiving Alpelisib for Metastatic Breast Cancer Have Hyperglycemia